• Biocelect

Tafenoquine inhibits replication of SARS-Cov-2 at pharmacologically relevant concentrations in vitro

Updated: Jul 16

60 Degrees Pharmaceuticals Announces Positive Results of Cell Culture Testing of

ARAKODA (tafenoquine) for COVID-19

Find full press release in attachment below

Tafenoquine Press Release July 2020pdf

Please find the link and attached document of the published article and findings below

Dow et al 2020 TQ COVID 19 20200708pdf

Biocelect Logo_Colour.png

Copyright 2019 Biocelect 

Suite 405, Level 4, 51 Rawson Street, Epping NSW, 2121,  Australia 

Level 5, Wynn Williams House, 47 Hereford Street, Christchurch 8013, New Zealand

Privacy Policy

  • LinkedIn Social Icon